Starling Oncology, Inc. STLN
Set alert
6.25 USD -0.28 -4.29%
At close · Nov 2
6.24 -0.01 -0.16%
After hours · Nov 2, 4:49 PM ET
6.23 Day range 6.53
2.32 52-week range 7.13
- YTD
- +75.56%
- 1 year
- +40.13%
- Open
- 6.53
- Prev close
- 6.53
- Mkt cap
- 636.98M
- Vol
- 1.46M
- Avg vol
- 1.37M
- EPS
- -0.28
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.23
- High
- 6.53
15m chart
Built from the cached five-day intraday bars.
Signals (26)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 10:55 AM | 13 hours ago |
| SMA: Bullish | Nov 2, 10:25 AM | 13 hours ago |
| SMA: Bullish | Nov 2, 10:25 AM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 10:25 AM | 13 hours ago |
| RSI: Oversold | Nov 2, 9:55 AM | 14 hours ago |
| SMA: Bearish | Nov 2, 9:40 AM | 14 hours ago |
| SMA: Bearish | Nov 2, 9:40 AM | 14 hours ago |
| MACD: Sell Signal | Nov 2, 9:40 AM | 14 hours ago |
| SMA: Bullish | Oct 30, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 1:55 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 11:25 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:10 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:40 AM | 3 days ago |
| RSI: Oversold | Oct 30, 9:40 AM | 3 days ago |
| SMA: Bearish | Oct 29, 12:55 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 12:25 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 10:10 AM | 4 days ago |
Newest 20 of 26.
Financials — quick view
STLN Revenue — quarterly 161.28M
STLN Net income — quarterly -8.24M
STLN EPS — quarterly -0.08
News
- Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call
- Needham Maintains Buy on Starling Oncology, Raises Price Target to $9
- Oncology Institute (NASDAQ:STLN) Shares Climb 6.1% – Should You Buy?
- Cedar Grove Capital Q3 2026 Portfolio Update
- Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
- Starling Oncology: Improving Cash Flow And Gross Profit Fuel A Re-Rating
- 12 Health Care Stocks Moving In Friday's After-Market Session
- Starling Oncology to Participate in Wells Fargo Healthcare Conference
- Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
- Starling Oncology Q2 EPS $(0.08) Up From $(0.15) YoY, Sales $161.282M Up From $119.802M YoY
Your note
Sign in to keep a note on STLN — it syncs with the Stock Master app.